Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the efficacy (disease response) and safety of mapatumumab in combination with carboplatin and paclitaxel as first line therapy in subjects with advanced non-sm...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Human Genome Sciences Inc.
NCT06312137 · Non Small Cell Lung Cancer
NCT06814496 · Melanoma, Medullary Thyroid Cancer, and more
NCT05671510 · Non Small Cell Lung Cancer
NCT07222566 · Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, and more
NCT03340506 · Melanoma, Non Small Cell Lung Cancer, and more
Birmingham Hematology and Oncology Associates, LLC
Birmingham, Alabama
Desert Hematology Oncology Medical Group, Inc.
Rancho Mirage, California
University of Colorado Health Sciences Center
Aurora, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions